Chemically modified double stranded nucleic acid molecules that mediate RNA interference
AssigneeSirna Therapeutics, Inc.
InventorsChandra Vargeese, Vasant Jadhav, David Morrissey
Life of this patent
Estimating the term…
Loading patent…
AssigneeSirna Therapeutics, Inc.
InventorsChandra Vargeese, Vasant Jadhav, David Morrissey
Estimating the term…
This invention relates to compounds, compositions, and methods useful for modulating gene expression using chemically modified double stranded nucleic acid molecules. In particular, the instant invention features double stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of genes via RNA interference (RNAi). The invention features various modifications to double stranded nucleic acid structures, including chemically modified overhangs and optimized stabilization motifs of guide (antisense) strand and passenger (sense) strands of double stranded nucleic acid molecules that allow for potent RNA interference in therapeutically relevant applications.
A double stranded nucleic acid molecule having structure SI:
A double stranded nucleic acid molecule having structure SII:
A double stranded nucleic acid molecule having structure SIII:
A double stranded nucleic acid molecule having structure SIV:
A double stranded nucleic acid molecule having structure SV:
A double stranded nucleic acid molecule having structure SVII:
A double stranded nucleic acid molecule having structure SVIII:
Dependencies are inferred from the claim text.